qGenomics
qGenomics is a Barcelona-based biotech that built genomics diagnostics tools, notably the qMatching Platform and qIntranet, for clinical and research users in Europe before being acquired by Veritas Genetics in September 2025.
- Company typePrivate
- Founded2008
- HeadquartersBarcelona, Spain
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What qGenomics does
qGenomics was a private biotechnology company headquartered in Barcelona, Spain, founded in 2008, that operated in the clinical genomics diagnostics vertical within the European market. The company built and maintained a focused product portfolio consisting of two offerings: the qMatching Platform (V.3), a web-accessible genomics matching platform enabling researchers and clinical professionals to match, compare, and analyze genomic data; and qIntranet, an internal management and operations platform providing authenticated access to organizational resources and workflows for staff and authorized users. Its value proposition centered on specialized genomics diagnostics capabilities for clinical applications, with domain specialization and ease of implementation cited as the primary technical differentiators.
The company operated with a small team of 11-50 employees and pursued a vertical segmentation approach targeting clinical and research genomics users. No pricing model, revenue mechanics, go-to-motion, named customers, or funding history is publicly documented in available sources, leaving the commercial structure of the business substantially opaque. On September 17, 2025, qGenomics was acquired by Veritas Genetics for an undisclosed amount, with the stated strategic intent of expanding Veritas's capabilities in genomics diagnostics and its European clinical market presence. Following the acquisition, qGenomics ceased operating as an independent entity, its primary website was replaced with a redirect notice, and its services, including the qMatching Platform and qIntranet, were integrated into and made available through Veritas Genetics' platform and infrastructure.
qGenomics firmographics
Firmographics- Name
- qGenomics
- Website
- https://qgenomics.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Acquired
- Headcount range
- 11–50 employees
- Short description
- qGenomics is a Barcelona-based biotech that built genomics diagnostics tools, notably the qMatching Platform and qIntranet, for clinical and research users in Europe before being acquired by Veritas Genetics in September 2025.
- Ownership category
- akta.pro rank
qGenomics industry classification
Industry- Product category
- Clinical Genomics Software
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)
- akta.pro secondary industries
- Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL)
Keywords
Where qGenomics is headquartered
LocationHeadquarters
- HQ city
- Barcelona
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
qGenomics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
qGenomics product offering
Product offeringCore offering
qGenomics provided genomics diagnostics services through its flagship qMatching Platform (V.3), enabling researchers and clinical professionals to match, compare, and analyze genomic data for clinical applications. It also offered the qIntranet tool for internal management and authenticated access to organizational resources. Following its acquisition by Veritas Genetics on September 17, 2025, these services were integrated into and made available through Veritas Genetics' platform.
Product overview
qGenomics offered a focused product portfolio consisting of two main offerings: the qMatching Platform (V.3), a genomics matching platform for analyzing and comparing genomic data, and qIntranet, an internal management tool for organizational access control. Following its acquisition by Veritas Genetics in September 2025, these services are now integrated into and available through Veritas Genetics' platform. The company operated as a unified product offering with the qMatching Platform serving as the primary public-facing product and qIntranet serving internal operational needs.
Differentiator
Problem solved
Functional benefit
Products and services
- qMatching Platform (V.3)
Companies that use qGenomics
Customer profileIdeal customer profiles1 record
qGenomics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
qGenomics partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Veritas GeneticscoreVeritas Genetics acquired qGenomics on September 17, 2025, for an undisclosed amount. The acquisition was strategic, aimed at expanding Veritas Genetics' capabilities in genomics diagnostics with focus on clinical applications and European market presence. Following the acquisition, qGenomics services are now integrated into and available through Veritas Genetics' platform and website.
Scale indicators1 record
Recent moves3 records
Expansion highlights3 records
qGenomics competitors and assessment
Company assessmentDirect peers
- BC Platforms: Genomics data and analytics platform with European presence, offering tools for genomic data management, matching, and clinical interpretation. Comparable both in capability and in regional focus.
- DNAnexus: Provides a cloud-based genomics data management and analysis platform used by clinical and research customers. Directly comparable to qMatching as a genomic data matching/analysis infrastructure layer for clinical applications.
- Congenica: Clinical genomics interpretation platform used by hospitals and labs for variant analysis and matching in clinical workflows. Closely comparable clinical-genomics analysis offering to qMatching.
- Fabric Genomics: AI-driven clinical genomics interpretation platform for variant matching and clinical reporting — directly overlaps with qMatching's clinical genomics matching and analysis positioning.
- Veritas Genetics: The acquirer of qGenomics and now its parent; Veritas Genetics is a clinical genomics company offering whole-genome sequencing and related diagnostic services, making it the most directly comparable operator given shared clinical-genomics focus.
Broad incumbents
- SOPHiA Genetics: European-headquartered clinical genomics analytics platform used by hospitals for matching and analyzing genomic data — broadly comparable to qMatching's clinical genomics matching/analysis purpose.
- Foundation Medicine: Large, established clinical genomics profiling and matching service for oncology — broader portfolio than qGenomics but analogous clinical-genomics matching/interpretation workflow.
- Illumina: Dominant sequencer and genomics-infrastructure vendor whose BaseSpace and connected analytic ecosystems encompass matching/analysis functions overlapping with qMatching's domain.
- Centogene: European-headquartered clinical genomics lab and diagnostic service provider focused on rare and hereditary disease testing, operating in a directly adjacent niche to qGenomics' clinical genomics focus.
Emerging players
- GenomOncology: Clinical genomics analytics company providing matching and analysis workflows for precision oncology; comparable as a niche analytics operator adjacent to qGenomics' matching platform.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
qGenomics social profiles
Digital presenceqGenomics financial estimates
Financial estimateRevenue estimate
Valuation estimate
qGenomics leadership team
Management profileNumber of profiles
qGenomics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
qGenomics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about qGenomics
What does qGenomics do?
qGenomics provided genomics diagnostics services through its flagship qMatching Platform (V.3), enabling researchers and clinical professionals to match, compare, and analyze genomic data for clinical applications. It also offered the qIntranet tool for internal management and authenticated access to organizational resources. Following its acquisition by Veritas Genetics on September 17, 2025, these services were integrated into and made available through Veritas Genetics' platform.
Is qGenomics a public or private company?
qGenomics is a private company. It is classified as corporate owned and is currently acquired.
When was qGenomics founded?
qGenomics was founded in 2008. It employs 11 to 50 people.
Where is qGenomics based?
qGenomics is headquartered in Barcelona, Spain, in the Europe region.
Who are qGenomics's main competitors?
Direct peers on record are BC Platforms, DNAnexus, Congenica, Fabric Genomics and Veritas Genetics. Broad incumbents are SOPHiA Genetics, Foundation Medicine, Illumina and Centogene. GenomOncology is listed as an emerging player.
Does qGenomics have an API?
No public API is recorded for qGenomics.
What industry is qGenomics in?
qGenomics's product category is Clinical Genomics Software. Its primary akta.pro industry code is HLAAALAD, Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics), with a secondary code of HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 621511 and its SIC code is 8071.